FdaApplication
ANDA 204663
Identifiers
- fda_app_no: ANDA204663
Properties
| Property | Value |
|---|---|
| applicant_name | ZYDUS PHARMACEUTICALS USA INC |
| application_type | ANDA |
| approval_date | 2017-06-28 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PHENTERMINE HYDROCHLORIDE | PHENTERMINE HYDROCHLORIDE | 15MG | TABLET, ORALLY DISINTEGRATING;ORAL |
| PHENTERMINE HYDROCHLORIDE | PHENTERMINE HYDROCHLORIDE | 30MG | TABLET, ORALLY DISINTEGRATING;ORAL |
| PHENTERMINE HYDROCHLORIDE | PHENTERMINE HYDROCHLORIDE | 37.5MG | TABLET, ORALLY DISINTEGRATING;ORAL |
3 products